Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-blind, active-controlled trial

American Journal of Rhinology

Volumn 12, Issue 6, 1998, Pages 441-449

  Finn Jr , Albert F ^a   Aaronson, Donald ^b   Korenblat, Phillip ^b   Lumry, William ^b   Settipane, Guy ^b   Spector, Sheldon ^b   Woehler, Thomas ^b   Drda, Kristin ^b   Wood, Chester C ^b  

^a National Allergy   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IPRATROPIUM BROMIDE; NOSE SPRAY; PLACEBO; TERFENADINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; EPISTAXIS; FEMALE; HEADACHE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE CONGESTION; NOSE IRRITATION; NOSE POLYP; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINORRHEA; SINUSITIS; SNEEZING; SYMPTOM;

EID: 0032409039     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065898780707919     Document Type: Article

References (23)

1. Smith JM. Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis (eczema). In Allergy: Principles and Practices, 2nd ed. Middleton E Jr., Reed CE, Ellis EF, Eds. St. Louis: CV Mosby Co, 771-803, 1983.
2. Jacobs RL. Nonallergic chronic rhinitis syndromes. Immunol Allergy Clin North Am 7:93-103, 1987.
3. Young P. Asthma and allergies: An optimistic future. Bethesda, MD: National Institutes of Health, March 1980:U.S. Public Health Service Publication No.(NIH)80-388.
4. Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French SF-36 Health Status Questionnaire. J Allergy Clin Immunol 94:182-88, 1994.
5. Kemp JP, Buckley CE, Gershwin ME, et al. Multicenter double blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis. Ann Allergy 54:502-509, 1985.
6. Meltzer EO. An overview of current pharmacotherapy in perennial rhinitis. J Allergy Clin Immunol 95:1097-1110, 1995.
7. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 269:1532-1536, 1993.
8. Meltzer EO, Orgel HA, Bronsky EA, et al. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: A study of its effects on their symptoms, quality of life, and nasal cytology. J Allergy Clin Immunol 90:242-249, 1992.
9. Druce HM, Spector SL, Fireman P, et al. Double-blind study of intranasal ipratropium bromide in nonallergic perennial rhinitis. Ann Allergy 69:53-60, 1992.
10. Diamond L, Dockhorn RJ, Grossman J, et al. A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol 95:1139-1146, 1995.
11. Hayden FG, Diamond L, Wood P, et al. Effectiveness and safety of intranasal ipratropium bromide in common colds. Ann Intern Med 125:89-97, 1996.
12. Baroody F, Majchel A, Roecker M, et al. Ipratropium bromide (Atrovent Nasal Spray) reduces the nasal response to methacholine. J Allergy Clin Immunol 89:1065-1075, 1992.
13. Wagenmann M, Baroody F, Jankowski R, et al. Onset and duration of inhibitory effect of ipratropium bromide nasal spray on methacholine induced nasal secretions. Clin Exp Allergy 24:288-290, 1994.
14. Baroody FM, Wagenmann M, Naclerio RM. A comparison of the secretory response of the nasal mucosa to methacholine and histamine. J Appl Physiol 74:2661-2671, 1993.
15. Baroody FM, Ford S, Lichtenstein LM, et al. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med 149:1457-1465, 1994.
16. Spector SL, Toshener D, Gay I, Rosenman E. Beneficial effects of propylene and polyethylene glycol and saline in the treatment of perennial rhinitis. Clin Allergy 12:187-196, 1982.
17. Jankowski R, Philip G, Togias A, Naclerio R. Demonstration of bilateral cholinergic secretory response after unilateral nasal cold, dry air challenge. Rhinology 32:97-100, 1993.
18. Bronsky EA, Druce H, Findlay SR, et al. A clinical trial of ipratropium bromide nasal spray in patients with perennial non-allergic rhinitis. J Allergy Clin Immunol 95:1117-1122, 1995.
19. Grossman J, Banov C, Boggs P, et al. Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications. J Allergy Clin Immunol 95:1123-1127, 1995.
20. Kaiser H, Findlay S, Georgitis J, et al. Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%. J Allergy Clin Immunol 95:1128-1132, 1995.
21. Storms W, Bodman S, Nathan R, et al. SCH 434: A new antihistamine/decongestant for seasonal allergic rhinitis. J Allergy Clin Immunol 83:1083-1090, 1989.
22. Package insert. SELDANE-D. In Physician Desk Reference (PDR) 1538-1540, 1996.
23. Package insert. CLARITIN-D. In Physician Desk Reference (PDR) 2350-2352, 1996.